Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

NCRI 2012

4 - 7 Nov 2012

ACV - AUSTRIA CENTER VIENNA, Vienna, Austria

Patient led funding for clinical trials

Dr Ian Lewis – Tenovus, Cardiff, UK

Patient led funding for clinical trials ( Dr Ian Lewis – Tenovus, Cardiff, UK )

Perception of inequalities in care and cancer registries

Sir Michael Richards – Department of Health, UK

Perception of inequalities in care and cancer registries ( Sir Michael Richards – Department of Health, UK )

Advances in haemato-oncological treatment options

Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK

Advances in haemato-oncological treatment options ( Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK )

Benefits of partaking in clinical trials

Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK

Benefits of partaking in clinical trials ( Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK )

Collaborations in clinical trials to bring new drugs to patients earlier

Dr Matt Seymour – National Cancer Research Network

Collaborations in clinical trials to bring new drugs to patients earlier ( Dr Matt Seymour – National Cancer Research Network )

Therapeutic exercise for patients with advanced cancer

Dr Matthew Maddocks – University of Nottingham, UK

Therapeutic exercise for patients with advanced cancer ( Dr Matthew Maddocks – University of Nottingham, UK )

Inequalities in cancer incidence, mortality and survival

Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK

Inequalities in cancer incidence, mortality and survival ( Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK )

Cancer in developing countries

Dr Ian Magrath – International Network for Cancer Research and Treatment, Brussels, Belgium

Cancer in developing countries ( Dr Ian Magrath – International Network for Cancer Research and Treatment, Brussels, Belgium )

Benefit of exercise to cancer survivors

Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands

Benefit of exercise to cancer survivors ( Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands )

Management of hepatocellular carcinoma

Dr Jean-Francois Dufour – University of Bern, Switzerland

Management of hepatocellular carcinoma ( Dr Jean-Francois Dufour – University of Bern, Switzerland )

Development of future cancer treatments

Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK

Development of future cancer treatments ( Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK )

Tissue donation and clinical trials

Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group

Tissue donation and clinical trials ( Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group )

The importance of hereditary genes to cancer susceptibility

Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA

The importance of hereditary genes to cancer susceptibility ( Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA )

Drug susceptibility in cancer cell lines

Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam

Drug susceptibility in cancer cell lines ( Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam )

Depression in cancer patients

Prof Mari Lloyd-Williams – University of Liverpool, UK

Depression in cancer patients ( Prof Mari Lloyd-Williams – University of Liverpool, UK )

Influence of cachexia on chemotherapy toxicity

Dr Michael Sawyer – University of Alberta, Canada

Influence of cachexia on chemotherapy toxicity ( Dr Michael Sawyer – University of Alberta, Canada )

Advances in the treatment of colorectal cancer

Dr Patrick Johnston - Queens University, Belfast, UK

Advances in the treatment of colorectal cancer ( Dr Patrick Johnston - Queens University, Belfast, UK )

New genetic sub-types of breast, ovarian and prostate cancer

Dr Paul Pharoah – University of Cambridge, UK

New genetic sub-types of breast, ovarian and prostate cancer ( Dr Paul Pharoah – University of Cambridge, UK )

A new approach to charity helpline services

Dr Rachel Iredale – Tenovus, Cardiff, UK

A new approach to charity helpline services ( Dr Rachel Iredale – Tenovus, Cardiff, UK )

A national study of cancer patient experiences

Dr Reg Race – Quality Health, Debyshire, UK

A national study of cancer patient experiences ( Dr Reg Race – Quality Health, Debyshire, UK )

Inequalities in cancer treatments

Dr Tony Moran – Christie NHS Foundation, Manchester, UK

Inequalities in cancer treatments ( Dr Tony Moran – Christie NHS Foundation, Manchester, UK )

Advances in the treatment of prostate cancer

Prof Malcolm Mason – Cardiff University, UK

Advances in the treatment of prostate cancer ( Prof Malcolm Mason – Cardiff University, UK )

Diet and exercise interventions for cancer survivors

Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham, Alabama, USA

Diet and exercise interventions for cancer survivors ( Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham, Alabama, USA )

Participation in clinical trials

Richard Stephens – VNCRI and NCRN Consumer Liaison Groups

Participation in clinical trials ( Richard Stephens – VNCRI and NCRN Consumer Liaison Groups )

Patient involvement in improvements in standard of care

Tom Haswell - VNCRI and NCRN Consumer Liaison Groups

Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )

Benefits of participating in clinical trials and patient liaison groups

Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups

Benefits of participating in clinical trials and patient liaison groups ( Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups )

More from ecancer